🇺🇸 FDA
Patent

US 10640534

Therapeutically active compositions and their methods of use

granted A61KA61K38/005A61K38/05

Quick answer

US patent 10640534 (Therapeutically active compositions and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/005, A61K38/05, A61K45/06, A61P